Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

Cochrane Movement Disorders Group

Research output: Contribution to journalLiterature reviewpeer-review

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases